TheraRadar
Clinical-Stage Companies / Zhaoke (Guangzhou) Ophthalmology

Zhaoke (Guangzhou) Ophthalmology

Pre-Approval PRO BETA
15
Total Trials
7
Phase 3
5
Phase 2
4
Recruiting
159
Score

Pipeline by Phase

Phase 3
7
Phase 2
5
Phase 1
3

Therapeutic Focus

Corneal Epithelial Defect Myopia Dry Eye Corneal Defect Corneal Diseases

Clinical Trials (15)

NCT06766357 Phase 3 RECRUITING

A Study of the Efficacy and Safety of Cyclosporin Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

Started: 4/3/2025

NCT06209281 Phase 3 ACTIVE NOT RECRUITING

A Phase III Clinical Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Started: 5/13/2022

NCT06209320 Phase 3 ACTIVE NOT RECRUITING

A Study of the Efficacy and Safety of Two Low-concentration Atropine Sulfate Eye Drops

Started: 3/15/2022

NCT06942793 Phase 3 NOT YET RECRUITING

A Study to Evaluate the Efficacy and Safety of Treatment With CsA-PG Ophthalmic Gel in Dry Eye Patients

Started: 5/20/2025

NCT06212973 Phase 3 COMPLETED

A Study to Evaluate the Efficacy and Safety of Epinastine Hydrochloride Eye Drops in the Treatment of Chinese Seasonal Allergic Conjunctivitis Patients

Started: 3/13/2023

NCT02617459 Phase 3 COMPLETED

Levobetaxolol Hydrochloride Eye Drops for Treatment of Primary Open-angle Glaucoma or Ocular Hypertension

Started: 1/4/2019

NCT04541888 Phase 3 COMPLETED

Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Moderate to Severe Dry Eye Disease

Started: 11/5/2020

NCT06948357 Phase 2 RECRUITING

Efficacy and Safety of BRIMOCHOL PF and CARBACHOL PF in Chinese Presbyopia Patients

Started: 3/24/2025

NCT07120308 Phase 2 COMPLETED

To Evaluate the Efficacy and Safety of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects Caused by Neurotrophic Keratitis

Started: 9/15/2021

NCT06209203 Phase 2 COMPLETED

A Phase II Clinical Trial to Evaluate the Efficacy and Safety of ZKY001 Eye Drops

Started: 8/3/2022

NCT06213727 Phase 2 COMPLETED

ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defects in a Phase Ⅱ Clinical Trial

Started: 3/15/2022

NCT03676335 Phase 2 COMPLETED

Assess the Safety and Efficacy of CsA Ophthalmic Gel in Subjects With Dry Eye

Started: 5/9/2018

NCT07132437 Phase 1 COMPLETED

Phase I Clinical Study of ZKY001 Eye Drops in the Treatment of Corneal Epithelial Defect

Started: 12/29/2021

NCT03967548 Phase 1 COMPLETED

The Germinal Peptide Eye Drops in Healthy Volunteers in a Clinical Study

Started: 4/9/2021

NCT03662971 Phase 1 COMPLETED

Evaluate the Tolerance, Safety and Pharmacokinetics of Germinal Peptide Eye Drops in Healthy Volunteers

Started: 10/29/2018

Drug Candidates

ZKY001 EYE DROPS ZKY001 eye drops Vehicle (placebo) Lower dose atropine sulfate eye drops Low dose atropine sulfate eye drops placebo Cyclosporine ophthalmic gel Cyclosporine ophthalmic gel vehicle BRIMOCHOL PF eye drops; CARBACHOL PF eye drops; Brimonidine eye drops; Placebo CsA-PG Ophthalmic Gel
Activity Status: Active
Last Trial Started: 5/20/2025
Last Trial Ended: 11/2/2023
Trials (12 months): 1
Completed Trials: 10
Data sourced from ClinicalTrials.gov. This company has no FDA-approved drugs.